Evidence map›Paper›PMID 40189577›Full record

ArticleAIDS research and therapy2025

"Swallowing these drugs every day, you get tired": a mixed-methods study to identify barriers and facilitators to retention and HIV viral load suppression among the adolescents living with HIV in TASO Mbale and TASO Soroti centers of excellence.

Bonniface Oryokot, Andrew Kazibwe, Abraham Ignatius Oluka, David Kagimu, Baker Bakashaba, Saadick Mugerwa Ssentongo, Twaha Mafabi, Charles Odoi, Abubaker Kawuba, Yunus Miya and 3 more

Abstract read
In one paragraph

Article in AIDS research and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Bonniface OryokotAIDS Information Center, Kampala, Uganda. bonory@gmail.com.
Andrew KazibweThe AIDS Support Organization (TASO), Kampala, Uganda.
Abraham Ignatius OlukaAIDS Information Center, Kampala, Uganda.
David KagimuThe AIDS Support Organization (TASO), Kampala, Uganda.
Baker BakashabaAIDS Information Center, Kampala, Uganda.
Saadick Mugerwa SsentongoAIDS Information Center, Kampala, Uganda.
Twaha MafabiThe AIDS Support Organization (TASO), Kampala, Uganda.
Charles OdoiThe AIDS Support Organization (TASO), Kampala, Uganda.
Abubaker KawubaThe AIDS Support Organization (TASO), Kampala, Uganda.
Yunus MiyaThe AIDS Support Organization (TASO), Kampala, Uganda.
Bernard Michael EtukoitThe AIDS Support Organization (TASO), Kampala, Uganda.
Kenneth MugishaAIDS Information Center, Kampala, Uganda.
Eleanor Namusoke-MagongoAIDS Control Program, Ministry of Health, Kampala, Uganda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdolescents aged 10-19 years, living with HIV (ALHIV) lag in attaining optimal viral load suppression (VLS) rates and retention in care. This study aimed to identify barriers and facilitators to both treatment outcomes in TASO Mbale and TASO Soroti centers of excellence.

methodsWe used a mixed methods approach, extracting secondary data on ALHIV who were active in care during April-June 2022 quarter to determine one year retention and VLS (HIV RNA copies < 1000/ml). Analysis was done in STATA Corp, 15.0. We used logistic regression to determine predictors and adjusted odds ratio (aOR) to report levels of predictability, using 95% confidence interval (CI) and P < 0.05 for statistical significance. For qualitative component, purposive sampling of 59 respondents was done. Focused group discussions, key informant interviews, and in-depth interviews were used to collect data. Thematic content analysis was done using Atlas ti.

resultsThere were 533 ALHIV, median age of 15 years, interquartile range of 11-18 and 54.2% females. 12-month retention rate was 95.9% and VLS of 84.0%. Poor and fair adherence [aOR = 0.044, 95% CI 0.010-0.196, P < 0.001)], [aOR = 0.010, 95% CI (0.002-0.039) P < 0.001] respectively had decreased odds for VLS while multi-month dispensing of drugs (aOR = 3.403, 95% CI 1.449-7.991, P = 0.005) had increased odds of VLS. For retention, being with a non-biological caregiver (aOR = 0.325, 95% CI 0.111-0.9482 P = 0.04) decreased the odds. Meanwhile key barriers included: individual ones such as internal stigma and treatment/drug fatigue; facility-level such as prolonged waiting time and lack of social activities; community level include stigma and discrimination, inadequate social support and food shortage. In terms of facilitators, individual level ones included good adherence and knowledge of one's HIV status; facility-level such as provision of adolescent friendly services and community-level like social support and decent nutrition.

conclusionsVLS rate was sub-optimal mainly due to poor adherence. HIV programs could utilize the barriers and facilitators identified to improve VLS. Conversely, retention rate at one year was good, likely due to provision of adolescent friendly health services. ALHIV and their caregivers need to be empowered to sustain retention and improve VLS.

Indexed as

Anti-HIV AgentsHIV InfectionsMedication AdherenceRetention in CareViral LoadAdolescentChildFemaleHumansMaleYoung AdultAnti-HIV AgentsAdolescentsBarriers and facilitatorsRetentionTASOViral load suppression

Identifiers

PMID40189577
PMCPMC11972455

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.